Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancer.

被引:0
|
作者
Tham, YL [1 ]
Gutierrez, C [1 ]
Weiss, H [1 ]
Mohsin, S [1 ]
Hilsenbeck, S [1 ]
Elledge, R [1 ]
Chamness, G [1 ]
Osborne, CK [1 ]
Allred, DC [1 ]
Chang, JC [1 ]
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:73S / 73S
页数:1
相关论文
共 50 条
  • [31] Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer
    Gentile, L.
    Plitas, G.
    Zabor, E.
    Stempel, M.
    Morrow, M.
    Barrio, A. V.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S67 - S67
  • [32] Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer
    Gentile, Lori F.
    Plitas, George
    Zabor, Emily C.
    Stempel, Michelle
    Morrow, Monica
    Barrio, Andrea V.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (13) : 3896 - 3902
  • [33] Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer
    Lori F. Gentile
    George Plitas
    Emily C. Zabor
    Michelle Stempel
    Monica Morrow
    Andrea V. Barrio
    [J]. Annals of Surgical Oncology, 2017, 24 : 3896 - 3902
  • [34] Good response to neoadjuvant chemoradiotherapy predicts good oncological outcome in locally advanced rectal cancer
    Zhang, Chi
    Xu, Liping
    Qin, Qin
    Liu, Jia
    Tang, Xinyu
    Jiang, Nan
    Zhang, Zhaoyue
    Li, Fei
    Cheng, Hongyan
    Chen, Jiayan
    Sun, Xinchen
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 (01) : 150 - 159
  • [35] Prediction of neoadjuvant chemotherapeutic efficacy by CTC and cfDNA in patients with locally advanced breast cancer.
    Ma, Ge
    Wang, Jingyi
    Liu, Xiaoan
    Xia, Tiansong
    Wang, Shui
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [36] Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer
    Kruger, Kristi
    Silwal-Pandit, Laxmi
    Wik, Elisabeth
    Straume, Oddbjorn
    Stefansson, Ingunn M.
    Borgen, Elin
    Garred, Oystein
    Naume, Bjorn
    Engebraaten, Olav
    Akslen, Lars A.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [37] Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer
    Kristi Krüger
    Laxmi Silwal-Pandit
    Elisabeth Wik
    Oddbjørn Straume
    Ingunn M. Stefansson
    Elin Borgen
    Øystein Garred
    Bjørn Naume
    Olav Engebraaten
    Lars A. Akslen
    [J]. Scientific Reports, 11
  • [38] Promising clinical and pathological response rates with neoadjuvant sequential doxorubicine (DOX) and docetaxel (DOC) in locally advanced breast cancer (LABC)
    Wynendaele, W
    Morales, L
    Christiaens, MR
    Wildiers, J
    Weltens, C
    Drijkoningen, E
    Van Limbergen, E
    Van den Bogaert, W
    van Oosterom, AT
    Paridaens, R
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S66 - S66
  • [39] Gut Microbiome Predicts Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Patients
    Shen, L.
    Yi, Y.
    Wang, Y.
    Zhang, J.
    Xia, F.
    Zhang, Z.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S46 - S47
  • [40] CLINICAL, MOLECULAR PROFILES AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER: AN INDIAN EXPERIENCE
    Arya, D.
    Parikh, B.
    Shah, P. M.
    Shukla, S. N.
    Patel, K. M.
    Anand, A. S.
    Talati, S.
    Shah, S. A.
    Patel, A. A.
    Parekh, B. B.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 134 - 134